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Summary
Objective:  The  primary  objective  of  this  study  was  to  determine  the  clinical  and  pathological
prognostic  factors  in  locally  advanced  oral  cavity  cancers  treated  by  primary  surgery.
Methods:  All  patients  treated  by  primary  surgery  with  free-ﬂap  reconstruction  for  locally
advanced oral  cavity  squamous  cell  carcinoma  in  our  institution  between  2000  and  2010  were
included  in  this  retrospective  study.  Overall,  cause-speciﬁc  and  locoregional  disease-free  sur-
vivals were  determined  by  Kaplan-Meier  analyses.  Clinical  and  histological  prognostic  factors
were assessed  by  univariate  (Log  Rank  tests)  and  multivariate  (Cox  models)  analyses.
Results:  A  total  of  149  patients  (102  men  and  47  women;  mean  age  =  61.3  ±  12.1  years)  were
included  in  the  study.  Five-year  overall,  cause-speciﬁc  and  locoregional  disease-free  survivals
were 55%,  68%  and  71%,  respectively.  Age,  comorbidity  and  tumour  size  (histological  evaluation)
were signiﬁcantly  correlated  with  overall  survival  (P  <  0.05).  Age,  tumour  size,  bone  invasion  and
surgical margins  were  signiﬁcantly  correlated  with  locoregional  disease-free  survival  (P  <  0.05).
∗ Corresponding author. Tel.: +33 6 83 39 78 72; fax: +33 4 92 03 17 64.
E-mail address: alexandre.bozec@nice.unicancer.fr (A. Bozec).
1879-7296/$ – see front matter © 2012 Elsevier Masson SAS. All rights reserved.
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Conclusion:  The  main  prognostic  factors  identiﬁed  in  this  study  were  clinical  (age  and  comor-
bidity) and  histological  (pathological  tumour  size,  bone  invasion  and  surgical  margins).
© 2012  Elsevier  Masson  SAS.  All  rights  reserved.
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ral  cavity  cancers  belong  to  the  group  of  upper  aerodi-
estive  tract  (UADT)  tumours,  which  represent  the  sixth
ost  common  form  of  cancer  in  France  [1].  Surgery,  when
ossible,  remains  the  reference  ﬁrst-line  treatment  for
ral  cavity  cancer.  For  locally  advanced  tumours,  surgery
s  followed  by  radiotherapy,  possibly  in  combination  with
oncomitant  chemotherapy.  Surgery  for  oral  cavity  cancer
omprises  often-complex  reconstruction  techniques  with
xtensive  use  of  free  ﬂaps  [2,3]. Many  clinical,  histologi-
al  or  biological  prognostic  factors  have  been  studied,  but
he  respective  role  of  the  various  factors  in  clinical  practice
as  yet  to  be  determined.  As  a  result  of  progress  in  surgery
resection  and  reconstruction  techniques)  and  postopera-
ive  treatment  (reﬁned  irradiation  techniques,  combination
ith  concomitant  chemotherapy),  the  results  of  treatment
n  terms  of  cancer  control  now  need  to  be  revised.
The  primary  objective  of  this  study  was  to  determine
he  clinical  and  histological  prognostic  factors  of  locally
dvanced  oral  cavity  cancer  treated  by  primary  surgery.  The
econdary  objectives  were  to  analyse  the  cancer  control
esults  obtained  and  to  compare  them  to  data  reported  in
he  literature.
aterials and methods
 retrospective  study  was  conducted  on  all  patients  treated
n  our  institution,  between  1st  January  2000  and  30  June
010.  Inclusion  criteria  were:  patients  with  locally  advanced
stage  III  or  IV  nonmetastatic)  oral  cavity  squamous  cell
arcinoma  treated  by  primary  surgery  including  free  ﬂap
econstruction,  with  no  previous  treatment  for  this  tumour.
xclusion  criteria  were:  early  tumour  (stage  I  or  II),  another
istological  type  of  tumour  or  a  tumour  not  involving  the
ral  cavity,  recurrent  tumour  after  previous  treatment.
Tumour  stage  was  evaluated  according  to  the  Interna-
ional  Union  Against  Cancer  (UICC)  2002  tumour,  node,
etastasis  (TNM)  classiﬁcation.  Patient  comorbidity  was
ssessed  by  using  the  Kaplan-Feinstein  index  (KFI)  [4].
Patients  included  in  this  series  were  followed  after  treat-
ent  according  to  the  guidelines  published  by  the  French
NT  Society  for  the  surveillance  of  patients  treated  for  upper
erodigestive  tract  cancer  [5].
The  following  clinical  and  histological  data  were
etrieved  by  retrospective  analysis  of  the  patients’  comput-
rized  medical  ﬁles: clinical  data:  gender,  age,  comorbidity,  tumour  site,
TNM  stage,  postoperative  radiotherapy,  development  of
tumour  recurrence,  patient’s  status  at  the  time  of  the
study  (alive,  dead,  cause  of  death);
i
n
w
n histological  data:  tumour  size  (maximum  diameter),
depth  of  invasion,  presence  of  vascular  embolus  and  per-
ineural  invasion,  bone  invasion,  tumour  differentiation,
cervical  lymph  node  invasion  (number  of  lymph  nodes
invaded,  lymph  node  sectors  invaded,  presence  of  cap-
sular  effraction),  surgical  margins  on  the  specimen,  ﬁnal
surgical  margins  (after  possible  complementary  resection
and  re-excision),  safety  margins  greater  than  or  less  than
5  mm.
Overall,  cause-speciﬁc  and  locoregional  recurrence-free
urvivals  were  calculated  by  the  Kaplan-Meier  method.
he  impact  of  clinical  factors  (age,  gender,  comorbidity,
 stage,  N  stage,  global  stage)  and  histological  factors
tumour  size,  depth  of  invasion,  presence  of  vascular
mbolus  and  perineural  invasion,  bone  invasion,  tumour  dif-
erentiation,  number  and  site  of  any  cervical  lymph  node
etastases,  presence  of  capsular  effraction,  surgical  mar-
ins  and  safety  margins),  on  overall,  cause-speciﬁc  and
ocoregional  recurrence-free  survivals  was  studied  by  uni-
ariate  analysis  (Log  Rank  tests)  followed  by  multivariate
nalysis  (Cox  models).  All  variables  associated  with  P  <  0.10
n  univariate  analysis  were  entered  into  the  multivariate
nalysis.  All  statistical  tests  were  performed  with  R.2.10.1
or  Windows  software,  with  a  limit  of  signiﬁcance  of  5%.
esults
atient  characteristics
 total  of  149  patients  (102  men  (68%)  and  47  women
31%),  with  a  mean  age  of  61.3  ±  12.1  years)  were  included
n  this  study.  The  patient  distribution  according  to  4
ncreasing  comorbidity  scores  (Kaplan-Feinstein  Index  [KFI])
as  as  follows:  KFI  =  0:43,  KFI  =  1:63,  KFI  =  2:36,  KFI  =  3:7
atients.  Cervical  lymph  node  dissection  was  performed
n  147  patients  (85  unilateral  lymph  node  dissections  and
2  bilateral  lymph  node  dissections).  Free  ﬂap  recon-
truction  surgery  used  a  forearm  fasciocutaneous  ﬂap
n  =  90),  lateral  thigh  fasciocutaneous  ﬂap  (n  =  3),  osteo-
utaneous  ﬁbula  ﬂap  (n  = 47),  osteocutaneous  scapula  ﬂap
n  =  2)  or  a  combination  of  osteocutaneous  ﬁbula  ﬂap
nd  forearm  fasciocutaneous  ﬂap  (n  =  7).  Postoperatively,
0  patients  received  exclusive  radiotherapy  and  58  received
oncomitant  platinum-based  chemoradiotherapy.  Thirty-
ne  patients  were  therefore  treated  by  surgery  alone
ithout  adjuvant  radiotherapy.
Mean  tumour  size  (maximum  diameter)  measured  on  his-
ological  sections  was  34.6  ±  15.6  mm  and  mean  depth  of
nvasion  was  19.2  ±  10.4  mm.  The  mean  number  of  lymph
ode  metastases  detected  in  cervical  lymph  node  dissections
as  1.6  ±  2.2,  with  capsular  effraction  in  a  mean  of  0.6  ±  1.2
odes.  Histologically  conﬁrmed  lymph  node  invasion  was
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Table  1  Clinical  and  histological  characteristics  of  149
patients  operated  for  locally  advanced  oral  cavity  cancer.
Characteristics  n  =  149  Percentage
Gender:  female/male  47/102  32/68
Age: >  70  years/  <  70  years  40/109  27/73
Comorbidity  KFI  <  2/KFI  ≥  2  106/43  71/29
T Stage
T2  11  7
T3 39  26
T4 99 67
Stage N
N0  80  54
N1 25  17
N2a, b  or  c  40  27
N3 4  3
Global tumour  stage:  III/IV 27/122 18/82
Bone  invasion  68  46
Perineural  invasion 24 16
Vascular  emboli  8  5
Tumour  differentiation
Well  differentiated 89 60
Moderately  differentiated 36 24
Poorly  differentiated 24 16
Depth  of  tumour  invasion
< 20  mm  104  70
> 20  mm  45  30
Lymph  node  invasion  94  64
Capsular  effraction  51  35
Positive  surgical  margins  25  17
Positive  ﬁnal  surgical  margins  5  4
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KFI: Kaplan-Feinstein Comorbidity Index.
observed  in  the  following  cervical  node  sectors:  IA:  ﬁve
cases,  Ib:  36  cases,  IIA:  58  cases,  IIB:  11  cases,  III:  32  cases,
IV:  ﬁve  cases,  V:  one  case.  Clinical  and  histological  charac-
teristics  of  the  patients  of  this  study  are  shown  in  Table  1.
Survival  and  prognostic  factors
Median  follow-up  in  this  study  was  47.7  months.  At  the  end
of  this  follow-up,  46  patients  presented  tumour  recurrence,
including  28  locoregional  recurrences,  nine  metastatic
recurrences  and  nine  combined  locoregional  and  metastatic
recurrences.  These  recurrences  occurred  after  a  mean  inter-
val  of  15.6  ±  11.8  months.
Overall  survival
Two,  3-  and  5-year  overall  survival  was  69%,  62%  and
55%,  respectively.  On  univariate  analysis,  age  (>  70  years;
P  =  0.01),  comorbidity  (KFI  2;  P  <  0.0001),  tumour  size
(>  30  mm;  P  =  0.03)  and  presence  of  lymphadenopathy  with
a
s
Tigure  1  Overall  survival  curve  for  149  patients  operated  for
ocally  advanced  oral  cancer.
apsular  effraction  (P  =  0.02)  had  a  statistically  signiﬁcant
egative  impact  on  overall  survival.  The  prognostic  role
f  age  (P  =  0.03),  comorbidity  (P  =  0.0002)  and  tumour  size
P  =  0.02)  was  conﬁrmed  on  multivariate  analysis.  In  con-
rast,  the  inﬂuence  of  lymphadenopathy  with  capsular
ffraction  on  overall  survival  was  not  conﬁrmed  on  multi-
ariate  analysis.
Fig.  1  shows  the  overall  survival  curve  for  all  patients.
ause-speciﬁc  survival
wo,  three-  and  ﬁve-year  cause-speciﬁc  survival  was  77%,
3%  and  68%,  respectively.  In  univariate  analysis,  age  (>  70
ears;  P  =  0.05),  comorbidity  (KFI  2;  P  =  0.002)  and  tumour
ize  (>  30  mm;  P  =  0.007)  had  a  statistically  signiﬁcant  neg-
tive  impact  on  cause-speciﬁc  survival.  These  results  were
onﬁrmed  on  multivariate  analysis  (age:  P  =  0.03;  comorbid-
ty:  P  =  0.02;  tumour  size:  P  =  0.006).
ocoregional  recurrence-free  survival
wo,  three-  and  ﬁve-year  locoregional  recurrence-free  sur-
ival  was  77%,  73%  and  71%,  respectively.  On  univariate
nalysis,  age  (>  70  years;  P  =  0.02),  comorbidity  (KFI  2;
 =  0.01),  tumour  size  (>  30  mm;  P  =  0.02),  bone  invasion
P  =  0.02),  ﬁnal  surgical  margins  (positive  margins;  P  =  0.04)
nd  safety  margins  (<  5  mm;  P  <  0.04)  had  a  statistically  sig-
iﬁcant  negative  impact  on  locoregional  recurrence-free
urvival.  On  multivariate  analysis,  only  the  patient’s  age
P  =  0.001),  tumour  size  (P  =  0.002),  bone  invasion  (P  =  0.04)
nd  ﬁnal  surgical  margins  (P  =  0.01)  still  had  a  statistically
igniﬁcant  impact  on  locoregional  recurrence-free  survival.
Histological  and  clinical  prognostic  factors  are  shown  in
ables  2  and  3.
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Table  2  Clinical  prognostic  factors  in  patients  operated  for  locally  advanced  oral  cavity  squamous  cell  carcinoma.
Clinical  parameters  Overall  survival  Cause-speciﬁc  survival  Locoregional
recurrence-free  survival
P  (UA)/(MA)  P  (UA)/(MA)  P  (UA)/(MA)
Age 0.01/0.03  0.05/0.03  0.02/0.001
Gender 0.32/—  0.59/—  0.24/—
Comorbidity  <  0.0001/0.0002  0.002/0.02  0.01/0.14
Adjuvant radiotherapy  0.61/—  0.55/—  0.69/—
T stage 0.45/— 0.42/—  0.41/—
N stage 0.25/— 0.16/— 0.51/—
P (UA): p value on univariate analysis (Log Rank tests); P (MA): p value on multivariate analysis (Cox models). All variables associated
with P < 0.10 on univariate analysis were entered into Cox models.
Age: > 70 years versus < 70 years; comorbidity (KFI: Kaplan-Feinstein index): KFI 2 versus KFI < 2; stage T: T2 or T3 versus T4; stage N:
N ≥ 1 versus N0.
Table  3  Histological  prognostic  factors  in  patients  operated  for  locally  advanced  oral  cavity  squamous  cell  carcinoma.
Histological  parameters  Overall  survival  Cause-speciﬁc  survival  Locoregional
recurrence-free  survival
P  (UA)/(MA) P  (UA)/(MA) P  (UA)/(MA)
Tumour  size 0.03/0.02 0.007/0.006 0.02/0.002
Depth  of  tumour  invasion  0.08/a 0.09/a 0.17/—
Bone invasion 0.31/— 0.13/— 0.02/0.04
Perineural  invasion  0.82/—  0.31/—  0.2/—
Vascular emboli 0.48/— 0.89/— 0.45/—
Tumour  differentiation  0.40/—  0.26/—  0.19/—
Lymph node  invasion 0.25/— 0.16/— 0.5/—
Capsular  effraction  0.02/0.11  0.12/—  0.88/—
Surgical margins  0.78/—  0.4/—  0.13/—
Final surgical  margins  0.92/—  0.49/—  0.04/0.01
Safety margins  0.2/—  0.55/—  0.04/0.3
P (UA): P (UA): P value on univariate analysis (Log Rank tests); P (MA): p value on multivariate analysis (Cox models). All variables
associated with P < 0.10 on univariate analysis were entered into Cox models.
Tumour size: maximum diameter > 30 mm versus ≤ 30 mm; tumour invasion: depth of invasion > 20 mm versus ≤ 20 mm;  safety margins
≥ 5 mm versus < 5 mm.
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iscussion
his  study  was  based  on  a  large,  homogeneous  patient
eries,  as  all  patients  included  in  this  study  had  locally
dvanced  oral  cavity  squamous  cell  carcinoma  treated  by
rimary  surgery.  The  treatment  of  oral  cavity  cancers  is  sur-
ical.  In  addition  to  the  usual  clinical  prognostic  factors,
istological  data  are  used  to  determine  the  indications  for
djuvant  therapy.  As  clearly  illustrated  by  this  series,  the
ajority  of  patients  with  locally  advanced  oral  cavity  cancer
ere  treated  by  adjuvant  radiotherapy  often  potentiated
y  a  platinum  salt.  Several  patients  can  nevertheless  be
t
[
tly related to tumour size.
ffectively  treated  by  surgery  alone,  after  wide  resection
nd  in  the  absence  of  any  poor  prognostic  factors.
Surgery  for  locally  advanced  oral  cavity  cancer  involves
omplex  reconstruction  techniques.  The  present  series
eﬂects  the  practice  reported  by  most  authors,  as  the  fore-
rm  fasciocutaneous  ﬂap  is  the  ﬂap  most  commonly  used
or  repair  of  extensive  mucosal  and  muscle  defects  of  the
ropharyngeal  region,  while  the  osteocutaneous  ﬁbula  ﬂap  is
he  ﬂap  most  commonly  used  for  mandibular  reconstruction
3,6—9].
In  the  current  context  of  rapid  growth  of  concomi-
ant  chemoradiotherapy  protocols  for  the  treatment  of
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Table  4  Survival  rates  recently  published  in  the  literature  compared  to  those  of  this  study.
Studies  Survival  rates  Comments
Our  study  5-year  OS  =  55%  (stages  III  and  IV)
5-year  CSS  =  68%
Retrospective  study,  primary  surgery
Blanchard et  al.,  2011.  [10]  5-year  OS  =  33%  (stage  III  and  IV)  Meta-analysis,  operated  and  non-operated
patients
Kang et  al.  in  press  [11]  5-year  CSS  =  63%  (stage  IV)
5-year  OS  =  55%  (all  T,  pN  +  )
Retrospective  study,  well  differentiated
squamous  cell  carcinomas,  primary  surgery
Arduino et  al.  2008.  [12]  5-year  OS  =  52%  (T4)  Retrospective  study,  operated  (88%)  and
non-operated  patients
Jan et  al.  2011.  [13] 5-year  OS  =  69%  (stage  III)
5-year  OS  =  53%  (stage  IV)
Retrospective  study,  operated  (95%)  and
non-operated  patients
Garzino-Demo  et  al.  2006  [14] 3-year  OS  =  49%  (stage  III  and  IV)  Retrospective  study,  primary  surgery
Husseiny et  al.  2000  [15]  5-year  OS  =  65%  (stage  I  to  IV)  Retrospective  study,  operated  (86%)  and
non-operated  patients
Choi et  al.  2006  [16] 5-year  OS  =  51%  (stage  IV) Retrospective  study,  operated  (76%)  and
non-operated  patients
OS: overall survival; CSS: cause-speciﬁc survival.
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iupper  aerodigestive  tract  tumours,  it  seemed  interesting  to
present  the  recent  cancer  control  results  of  primary  surgery
in  locally  advanced  oral  cavity  cancer,  in  which  treatment
remains  essentially  surgical  [2].  The  median  follow-up  in
this  study,  almost  4  years,  was  suitable  for  analysis  of  sur-
vival  and  prognostic  factors,  as  tumour  recurrences  occurred
after  a  mean  interval  of  about  15  months.  The  survival
rates  reported  in  this  study,  comprising  more  than  80%  of
patients  with  a  stage  IV  tumour,  appear  to  be  satisfac-
tory,  particularly  for  5-year  cause-speciﬁc  and  locoregional
recurrence-free  survivals  (68%  and  71%,  respectively).  Local
disease  progression  can  therefore  be  avoided  in  more  than
two-thirds  of  patients.  This  result  must  be  emphasized  in
view  of  the  major  impact  of  local  recurrence  on  the  patient’s
quality  of  life.  The  survival  rates  reported  in  this  study  are
consistent  with  those  reported  in  recent  studies  (Table  4)
[10—16].
Advanced  age  and  high  comorbidity  appeared  to  be
the  main  clinical  prognostic  factors  in  this  study,  as  also
reported  by  many  authors  for  various  upper  aerodigestive
tract  tumour  sites,  whether  or  not  the  primary  treatment
was  surgery  [17—20], as  elderly  patients  or  patients  in
poor  general  health  are  more  vulnerable  to  progression  of
disease  and  often  require  simpliﬁcation  of  the  treatment
sequence  (frequent  contraindications  to  adjuvant  concomi-
tant  chemotherapy).  Tumour  stage  was  not  identiﬁed  as  a
prognostic  factor  in  this  study,  which  can  be  explained  by
the  homogeneity  of  the  study  population  in  terms  of  initial
extent  of  the  disease.  No  prognostic  impact  of  tumour  stage
was  demonstrated  in  this  study,  as  all  patients  presented
locally  advanced  tumour.
The  main  histological  prognostic  factor  was  the  maximum
tumour  diameter.  This  may  appear  to  be  somewhat  surpris-
ing,  as  tumour  size  is  one  of  the  main  determinants  of  T
s
g
s
[tage,  which  did  not  have  any  prognostic  impact  in  this  study.
owever,  in  addition  to  tumour  size,  T  stage  also  takes  into
ccount  invasion  of  certain  structures  such  as  the  mandible
r  extrinsic  muscles  of  the  tongue.  Clinical  evaluation  of  T
tage  may  also  be  subject  to  relatively  marked  interindi-
idual  variation.  Precise  measurement  of  maximum  tumour
iameter  on  histological  sections  therefore  appears  to  be  a
ore  relevant  prognostic  factor  than  T  stage.  The  depth  of
umour  invasion  tended  to  have  a  prognostic  impact,  but  was
ot  statistically  signiﬁcant.  The  presence  of  bone  invasion
nd  the  surgical  margin  status  (ﬁnal  margins  after  possible
omplementary  resection  and  re-excision)  had  a  negative
mpact  on  prognosis,  and  more  speciﬁcally  on  locoregional
ecurrence-free  survival,  emphasizing  the  importance  of
he  quality  of  surgical  resection  in  terms  of  prognosis.  Pri-
ary  surgery  is  only  indicated  for  the  treatment  of  upper
erodigestive  tract  tumours  if  it  allows  complete  resection
f  the  primary  tumour.  In  the  present  study,  surgical  mar-
ins  were  considered  to  be  negative  for  96%  of  patients.
ome  histological  factors  usually  shown  to  have  a  progno-
tic  impact  in  oral  cavity  cancer  were  not  conﬁrmed  by
his  study  [11—13]. For  example,  the  poorly  differentiated
ature  of  the  tumour,  the  presence  of  perineural  invasion,
ascular  emboli,  cervical  lymph  node  metastases  or  capsu-
ar  effraction  were  not  identiﬁed  as  prognostic  factors  in
his  study.  In  a  recent  study  based  on  467  patients  with  oral
avity  squamous  cell  carcinoma,  Kang  et  al.  demonstrated
he  major  prognostic  impact  of  depth  of  tumour  invasion  and
ervical  lymph  node  invasion  (more  than  two  lymph  nodes
nvaded,  invasion  of  levels  IV  and  V)  [11]. In  another  recent
tudy,  Jan  et  al.  demonstrated  the  prognostic  impact  of  sur-
ical  margins,  as  well  as  the  prognostic  impact  of  tumour
tage  and  capsular  effraction  on  cervical  lymphadenopathies
13].
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onclusion
n  this  study,  primary  surgery  for  locally  advanced  oral  cav-
ty  cancer  achieved  5-year  local  control  in  more  than  70%  of
ases.  The  main  clinical  prognostic  factors  were  age  and
omorbidity.  In  contrast  with  T  stage,  tumour  size  mea-
ured  on  histological  sections  was  identiﬁed  as  one  of  the
ain  prognostic  factors.  Bone  invasion  and  surgical  margins
ere  the  other  two  histological  parameters  with  a  pejora-
ive  impact  on  prognosis.
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